Skip to contentJANNEY DANIEL — Krystal Biotech, Inc. insider: 204 transactions · InsiderLensJANNEY DANIEL
- Director at COTHERIX INC · on record since Jan 19, 2006
- 10% owner at COTHERIX INC · on record since Jan 19, 2006
- 10% owner at CUTERA INC · on record since Mar 30, 2004
- Director at DYNAVAX TECHNOLOGIES CORP · on record since Jun 16, 2006
- No longer a Director at DYNAVAX TECHNOLOGIES CORP · on record since Nov 14, 2006
- No longer 10% owner at OCCAM NETWORKS INC/DE · on record since Nov 7, 2006
- 10% owner at AXONYX INC · on record since Oct 5, 2006
- Nolonger Director or 10% Owner at COTHERIX INC · on record since Jan 9, 2007
- 10% owner at NeurogesX Inc · on record since May 8, 2007
- 10% owner at ATS MEDICAL INC · on record since Jul 2, 2007
- 10% owner at CORGENTECH INC · on record since Dec 19, 2007
- 10% owner at AERIE PHARMACEUTICALS INC · on record since Oct 25, 2013
- Director at CORGENTECH INC · on record since Feb 8, 2008
- 10% owner at OCCAM NETWORKS INC/DE · on record since May 7, 2004
- No longer 10% owner at AXONYX INC · on record since Sep 8, 2009
- 10% owner at ACELRX PHARMACEUTICALS INC · on record since Feb 18, 2011
- 10% owner at FLAMEL TECHNOLOGIES SA · on record since Sep 17, 2003
- 10% owner at ELLIE MAE INC · on record since Apr 21, 2011
- See Footnote at FLAMEL TECHNOLOGIES SA · on record since Oct 3, 2003
- Director at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
- 10% owner at TREVENA INC · on record since Jan 30, 2014
- 10% owner at APPLIED GENETIC TECHNOLOGIES CORP · on record since Mar 26, 2014
- Director at RENOVIS INC · on record since Feb 4, 2004
- 10% owner at RENOVIS INC · on record since Feb 4, 2004
- 10% owner at ZS Pharma, Inc. · on record since Jun 25, 2014
- Former 10% Owner at CORGENTECH INC · on record since Feb 18, 2004
- 10% owner at Immune Design Corp. · on record since Jul 31, 2014
- Director at PLC SYSTEMS INC · on record since Sep 30, 2014
- 10% owner at PLC SYSTEMS INC · on record since Sep 30, 2014
- Director at Neothetics, Inc. · on record since Nov 25, 2014
- 10% owner at Neothetics, Inc. · on record since Nov 25, 2014
- 10% owner at Esperion Therapeutics, Inc. · on record since Oct 21, 2014
- 10% owner at Lifeline Systems, Inc. · on record since May 14, 2015
- 10% owner at KalVista Pharmaceuticals, Inc. · on record since Apr 14, 2015
- Former 10% Owner at Neothetics, Inc. · on record since Dec 30, 2015
- 10% owner at ICAGEN INC · on record since Feb 3, 2005
- Director at Krystal Biotech, Inc. · on record since Sep 25, 2017
- No longer 10% Owner at CUTERA INC · on record since Feb 23, 2005
- Director at SUTRO BIOPHARMA, INC. · on record since Sep 27, 2018
- 10% owner at SUTRO BIOPHARMA, INC. · on record since Sep 27, 2018
- Director at Allakos Inc. · on record since Jul 23, 2018
- 10% owner at Allakos Inc. · on record since Jul 23, 2018
- 10% owner at Tyra Biosciences, Inc. · on record since Sep 17, 2021
- No longer 10% Owner at RENOVIS INC · on record since Aug 9, 2005
- 10% owner at INTARCIA THERAPEUTICS, INC · on record since Sep 20, 2005
Insider trading activity of JANNEY DANIEL
- Transactions on record
- 204
- since Feb 18, 2004
- Open-market buys
- 12
- $29.7M
- Open-market sells
- 67
- $83.1M
- Companies traded
- 12
- last filing Mar 3, 2026
Figures computed from official regulatory filings — methodology.
Companies where JANNEY DANIEL has traded
- Krystal Biotech, Inc.51 tx · $46.1M · Mar 3, 2026
- Allakos Inc.18 tx · $12.6M · May 30, 2023
- Esperion Therapeutics, Inc.26 tx · $30.3M · May 28, 2021
- SUTRO BIOPHARMA, INC.10 tx · Jun 19, 2019
- PLC SYSTEMS INC24 tx · $5.7M · Jan 2, 2019
- Neothetics, Inc.3 tx · $762.1K · Dec 17, 2015
- ZS Pharma, Inc.5 tx · $16.5M · Jun 9, 2015
- APPLIED GENETIC TECHNOLOGIES CORP5 tx · $1.9M · Apr 1, 2014
- CORGENTECH INC16 tx · $36.4K · Jan 8, 2010
Track record of JANNEY DANIEL
Statistical track record
Free- Open-market buys
- 13
- Last buy
- Sep 21, 2022
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of JANNEY DANIEL
Co-insiders of JANNEY DANIEL
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
2 tx · $3.5M · Jul 3, 2008
ALTA CALIFORNIA PARTNERS II LPAXONYX INC +4
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 3, 2026 | Sell | -9,430 | 275.45 USD | $2.6M | SEC |
| Mar 3, 2026 | Sell | -2,373 | 276.17 USD | $655.4K | SEC |
| Feb 26, 2026 | Sell | -2,425 | 274.90 USD | $666.6K | SEC |
| Feb 26, 2026 | Exercise | 37,895 | 2.46 USD | $93.2K | SEC |
| Feb 26, 2026 | Sell | -6,671 | 268.04 USD | $1.8M | SEC |
| Feb 26, 2026 | Sell | -8,986 | 266.18 USD | $2.4M | SEC |
| Feb 26, 2026 | Sell | -1,674 | 268.67 USD | $449.8K | SEC |
| Feb 26, 2026 | Sell | -4,339 | 266.62 USD | $1.2M | SEC |
| Feb 26, 2026 | Sell | -1,733 | 264.12 USD | $457.7K | SEC |
| Feb 26, 2026 | Sell | -2,638 | 276.32 USD | $728.9K | SEC |
| Feb 26, 2026 | Sell | -62 | 263.05 USD | $16.3K | SEC |
| Feb 26, 2026 | Sell | -11,673 | 266.97 USD | $3.1M | SEC |
| Feb 26, 2026 | Sell | -3,963 | 268.97 USD | $1.1M | SEC |
| Feb 26, 2026 | Sell | -569 | 262.91 USD | $149.6K | SEC |
| Feb 26, 2026 | Sell | -1,604 | 265.54 USD | $425.9K | SEC |
| Feb 26, 2026 | ExerciseD | -37,895 | 0.00 USD | $0 | SEC |
| Feb 26, 2026 | Sell | -373 | 271.09 USD | $101.1K | SEC |
| Feb 26, 2026 | Sell | -3,557 | 265.08 USD | $942.9K | SEC |
| Feb 26, 2026 | Sell | -900 | 264.60 USD | $238.1K | SEC |
| Feb 26, 2026 | Sell | -700 | 275.00 USD | $192.5K | SEC |
| Feb 26, 2026 | Sell | -5,103 | 275.28 USD | $1.4M | SEC |
| Feb 26, 2026 | Sell | -370 | 269.83 USD | $99.8K | SEC |
| Feb 26, 2026 | Sell | -1,891 | 267.37 USD | $505.6K | SEC |
| Feb 26, 2026 | Sell | -930 | 269.50 USD | $250.6K | SEC |
| Jun 30, 2025 | AwardD | 5,000 | 0.00 USD | $0 | SEC |